![Michael Tung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Tung
Direttore Finanziario/CFO presso
VTV THERAPEUTICS INC.
Patrimonio netto: 375 188 $ in data 31/05/2026
Profilo
Michael Stephen Tung is Chief Financial Officer at vTv Therapeutics, Inc. since 2025.
Formerly, Dr. Tung was Chief Financial Officer at AdvanCell Isotopes Pty Ltd. from 2023 to 2025, Vice President-Strategy & Investor Relations at Kyntra Bio, Inc. from 2020 to 2023, Senior VP-Strategy & Investor Relations at Aclaris Therapeutics, Inc. from 2016 to 2020, Vice President at Nomura Investment Management Business Trust from 2006 to 2010, Portfolio Manager at Turner Investments LP from 2013 to 2014, Analyst at Galleon Management LP.
from 2005 to 2006, Analyst at Tekla Capital Management LLC from 2003 to 2005, Junior Analyst at Durus Capital Management LLC in 2003, Anesthesiologist at Beth Israel Deaconess Medical Center, Inc. from 2001 to 2003, Senior Analyst at Expo Capital Management LLC, and Analyst at Galleon Management LP.
Education includes an MBA and doctorate from Tufts University School of Medicine conferred in 2001, and an undergraduate degree from George Washington University conferred in 1997.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/04/2026 | 11.250 ( 0,29% ) | 375 188 $ | 31/05/2026 |
Posizioni attive di Michael Tung
| Società | Posizione | Inizio |
|---|---|---|
| VTV THERAPEUTICS INC. | Direttore Finanziario/CFO | 19/05/2025 |
Precedenti posizioni note di Michael Tung
| Società | Posizione | Fine |
|---|---|---|
AdvanCell Isotopes Pty Ltd.
 AdvanCell Isotopes Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a radiopharmaceutical firm | Direttore Finanziario/CFO | 01/01/2025 |
| KYNTRA BIO, INC. | Contatto Relazioni con gli Investitori | 01/07/2023 |
| ACLARIS THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | 01/04/2020 |
Nomura Investment Management Business Trust
 Nomura Investment Management Business Trust Investment ManagersFinance MIMBT maintains a flexible strategy designed to conform with various clients’ individual investment objectives. The firm manages separate client-focused equity, debt, and balanced portfolios. They invest in the public equity and debt markets of the US, non-US, and other emerging economies. MIMBT seeks growth-oriented value stocks of small-cap, mid-cap and large-cap companies. The firm selects countries by utilizing a top-down approach and selects stocks using fundamental analysis with a bottom-up approach. | Analyst-Equity | 31/07/2010 |
Galleon Management LP.
 Galleon Management LP. Investment ManagersFinance Provides investment advice | Analyst-Equity | 30/06/2006 |
Formazione di Michael Tung
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
85
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Nomura Investment Management Business Trust
Nomura Investment Management Business Trust Investment ManagersFinance MIMBT maintains a flexible strategy designed to conform with various clients’ individual investment objectives. The firm manages separate client-focused equity, debt, and balanced portfolios. They invest in the public equity and debt markets of the US, non-US, and other emerging economies. MIMBT seeks growth-oriented value stocks of small-cap, mid-cap and large-cap companies. The firm selects countries by utilizing a top-down approach and selects stocks using fundamental analysis with a bottom-up approach. | Finance |
Galleon Management LP.
Galleon Management LP. Investment ManagersFinance Provides investment advice | Finance |
Durus Capital Management LLC
 Durus Capital Management LLC Investment ManagersFinance Durus invests long/short in the small-cap healthcare technology sector. | Finance |
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
Tekla Capital Management LLC
 Tekla Capital Management LLC Investment ManagersFinance Tekla primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries. | Finance |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Expo Capital Management LLC
 Expo Capital Management LLC Investment ManagersFinance Expo manages Capital Management manages a healthcare sector long/short equity hedge fund called the Expo Health Sciences Fund. | Finance |
Turner Investments LP
 Turner Investments LP Investment ManagersFinance Turner Investments manages a variety of investment strategies focused on growth, including US domestic, global, international and long/short research-driven equity strategies. The firm also manages and administers the Turner Funds, a family of US mutual funds, and the Turner Funds plc, a family of two UCITS funds administered in Dublin, Ireland. Turner Investments' investment philosophy focuses on the long-term and seeks to achieve consistently superior investment returns. The firm employs a disciplined, systematic investment processes for each of their investment strategies and actively manages client portfolios to balance risk and return. Their investment processes are primarily based on in-depth, bottom-up fundamental research analysis, complemented by quantitative and technical analysis. | Finance |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
vTv Therapeutics, Inc.
 vTv Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company which engages in discovery and development of orally administered small molecule drugs for treating metabolic and inflammatory disorders | Health Technology |
AdvanCell Isotopes Pty Ltd.
AdvanCell Isotopes Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a radiopharmaceutical firm | Commercial Services |
